Clinical trials
Phase 2 Purpura, Thrombocytopenic, Idiopathic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| GlaxoSmithKline | 2 |
| Amgen | 1 |
| Bioverativ, a Sanofi company | 1 |
| Imperial College Healthcare NHS Trust | 1 |
| Incyte Corporation | 1 |
| Pfizer | 1 |
| Principia Biopharma, a Sanofi Company | 1 |
| Symphogen A/S | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 13 |
| Purpura | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| COVID-19 | 1 |
| Hemorrhage | 1 |
| Leukemia | 1 |
| Lymphoma | 1 |
| Neoplasms, Plasma Cell | 1 |
| Purpura, Thrombotic Thrombocytopenic | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.